Reaction Calorimetry for Process Safety
- Application of Isothermal Calorimetry for Inherently Safer Reactor Design
Jinyao Wang - Texas A&M University
- Multi-Scale PAT Capabilities to Enhance Small Molecule Development
Zachary Dance - Merck & Co., Inc.
- Streamlined Reaction Engineering Approach for Robust and Scalable Process Design
Rahul Sangodkar - Amgen
Each presentation will be followed by a live Q&A session with the presenter.
Who Should Attend?
Process Chemists and Chemical Engineers who need to:
- Assess Scalability with considerations for safety and robustness which may influence route selection
- Understand Reaction Mechanisms such as critical reaction parameters, kinetics, reaction intermediates, or limits of heat exchange
- Increase Efficiency with techniques that provide more comprehensive data collection without the wait for offline results
There is no cost to attend but registration is required and space is limited.
Your Online Seminar Presenters include:
Jingyao Wang, Texas A&M University, College Station
Jingyao Wang is currently a 3rd year chemical engineering Ph.D. student in Texas A&M University, College Station. He is also a graduate research assistant in Mary Kay O’Connor Process Safety Center. He is advised by Dr. M. Sam Mannan and co-advised by Dr. Benjamin Wilhite. His work focuses on inherently safer reactor design using both experimental and computational approach. Prior to joining Texas A&M University, He completed his undergraduate degree in chemical engineering in Rutgers University, New Brunswick, NJ advised by Dr. Marianthi Ierapetritou.
Zachary Dance, Merck & Co., Inc.
After receiving his PH.D. in Physical Organic Chemistry from Northwestern University in 2007, Dr. Dance joined Merck’s Center for Materials Science and Engineering. He then developed expertise in solid state characterization and PAT specifically in materials of pharmaceutical interest. For the last three years, Dr. Dance has led the Merck Research Labs Small Molecule PAT team. He has experience supporting development at all scales, troubleshooting, process optimization, and experimental design related to synthetic reaction understanding and physicochemical properties of APIs and excipients, as well as contributing results and interpretation to multiple patent and regulatory filings.
Rahul Sangodkar, Amgen
Rahul Sangodkar is a Senior Engineer in Amgen's Drug Substance Process Development organization in Cambridge, MA. In this role, he has been contributing towards chemical process design, modeling, and technology transfer during commercial process development of small molecule programs. Prior to his existing role, he completed his graduate research in Chemical Engineering at the University of California, Santa Barbara.